HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 445-456 of 1,979
Behavioral study icon
CompletedNCT02843282

Reasoning Training in Individuals With Bipolarity

Official study title

Brain & Cognitive Changes After Reasoning Training in Individuals With Bipolar Disorder

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityBehavioural studyAges 20–70
Countries
Sponsor
The University of Texas at Dallas
Drug study icon
CompletedNCT00177164

Risperdal Consta for Bipolarity

Official study title

A Random Assignment,Parallel Group, Open Label Comparison of Clinical Outcomes and Resource Utilization Among Bipolar Disorder Patients Receiving Either Long Acting Injectable Risperidone Microspheres (Risperdal Consta® ) or Other Second Generation Oral Antipsychotic Agents: A 15 Month Study

This study has finished and is no longer accepting participants.

Multiple locations, including Bridgeville
BipolarityMedication studyAges 18–70
Countries
United States
Sponsor
University of Pittsburgh
Device study icon
CompletedNCT05964777

rTMS-tACS Stimulation on Improving Cognitive Function in Bipolarity

Official study title

Efficacy and Safety of rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder: a Randomized, Double-blind, Sham Controlled Study

This study has finished and is no longer accepting participants.

In Hangzhou
BipolarityDevice studyAges 14–45
Countries
China
Sponsor
First Affiliated Hospital of Zhejiang University
Drug study icon
CompletedNCT00257166

Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolarity type I (Manic or Mixed)

Official study title

Four Week, Double-Blind, Placebo Controlled Phase III Trial Evaluating The Efficacy, Safety And Pharmacokinetics Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)

This study has finished and is no longer accepting participants.

Multiple locations, including Scottsdale
BipolarityMedication studyAges 10–17
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Drug study icon
WithdrawnNCT01117220

Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolarity type I (Manic Or Mixed) (Protocol A1281196)

Official study title

Four Week, Double Blind, Placebo Controlled Phase III Trial Evaluating The Efficacy, Safety And Pharmacokinetics Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)

This study was withdrawn before enrollment.

Location not clearly listed
BipolarityMedication studyAges 10–17
Countries
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Drug study icon
CompletedNCT00265330

Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolarity type I (Manic or Mixed)

Official study title

26-Week Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)

This study has finished and is no longer accepting participants.

Multiple locations, including Scottsdale
BipolarityMedication studyAges 10–17
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.